These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
651 related articles for article (PubMed ID: 30142350)
1. Impact of a higher fecal immunochemistry test cut-off on pathology detected in subsequent rounds of a colorectal screening program. Gibson DJ; Mooney T; Mooney J; Mulcahy HE; O'Donoghue D Gastrointest Endosc; 2019 Mar; 89(3):518-522. PubMed ID: 30142350 [TBL] [Abstract][Full Text] [Related]
2. Fecal immunochemical test in colorectal cancer screening: Colonoscopy findings by different cut-off levels. Ribbing Wilén H; Blom J; Höijer J; Hultcrantz R J Gastroenterol Hepatol; 2019 Jan; 34(1):103-112. PubMed ID: 29968937 [TBL] [Abstract][Full Text] [Related]
3. Lower Abnormal Fecal Immunochemical Test Cut-Off Values Improve Detection of Colorectal Cancer in System-Level Screens. Berry E; Miller S; Koch M; Balasubramanian B; Argenbright K; Gupta S Clin Gastroenterol Hepatol; 2020 Mar; 18(3):647-653. PubMed ID: 31085338 [TBL] [Abstract][Full Text] [Related]
4. Performance of two faecal immunochemical tests for the detection of advanced neoplasia at different positivity thresholds: a cross-sectional study of the Dutch national colorectal cancer screening programme. de Klerk CM; Wieten E; Lansdorp-Vogelaar I; Bossuyt PM; Spaander MC; Dekker E Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):111-118. PubMed ID: 30497962 [TBL] [Abstract][Full Text] [Related]
5. Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program. Wieten E; Schreuders EH; Nieuwenburg SA; Hansen BE; Lansdorp-Vogelaar I; Kuipers EJ; Bruno MJ; Spaander MC Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1771-1777. PubMed ID: 27567693 [TBL] [Abstract][Full Text] [Related]
6. Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal Neoplasia. Kapidzic A; van der Meulen MP; Hol L; van Roon AH; Looman CW; Lansdorp-Vogelaar I; van Ballegooijen M; van Vuuren AJ; Reijerink JC; van Leerdam ME; Kuipers EJ Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1464-71.e4. PubMed ID: 25724706 [TBL] [Abstract][Full Text] [Related]
7. Faecal haemoglobin concentration among subjects with negative FIT results is associated with the detection rate of neoplasia at subsequent rounds: a prospective study in the context of population based screening programmes in Italy. Senore C; Zappa M; Campari C; Crotta S; Armaroli P; Arrigoni A; Cassoni P; Colla R; Fracchia M; Gili F; Grazzini G; Lolli R; Menozzi P; Orione L; Polizzi S; Rapi S; Riggi E; Rubeca T; Sassatelli R; Visioli C; Segnan N Gut; 2020 Mar; 69(3):523-530. PubMed ID: 31455608 [TBL] [Abstract][Full Text] [Related]
8. Immunochemical faecal occult blood testing to screen for colorectal cancer: can the screening interval be extended? Haug U; Grobbee EJ; Lansdorp-Vogelaar I; Spaander MCW; Kuipers EJ Gut; 2017 Jul; 66(7):1262-1267. PubMed ID: 27006184 [TBL] [Abstract][Full Text] [Related]
9. Impact of age- and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening. Alvarez-Urturi C; Andreu M; Hernandez C; Perez-Riquelme F; Carballo F; Ono A; Cruzado J; Cubiella J; Hernandez V; Mao CG; Perez E; Salas D; Andrés M; Bujanda L; Portillo I; Sarasqueta C; Quintero E; Morillas JD; Lanas A; Sostres C; Augé JM; Castells A; Bessa X; Dig Liver Dis; 2016 May; 48(5):542-551. PubMed ID: 26936343 [TBL] [Abstract][Full Text] [Related]
10. Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program. Auge JM; Pellise M; Escudero JM; Hernandez C; Andreu M; Grau J; Buron A; López-Cerón M; Bessa X; Serradesanferm A; Piracés M; Macià F; Guayta R; Filella X; Molina R; Jimenez W; Castells A; Gastroenterology; 2014 Sep; 147(3):628-636.e1. PubMed ID: 24937264 [TBL] [Abstract][Full Text] [Related]
11. Fecal immunochemical test in cancer screening - colonoscopy outcome in FIT positives and negatives. Ribbing Wilén H; Blom J; Höijer J; Andersson G; Löwbeer C; Hultcrantz R Scand J Gastroenterol; 2019 Mar; 54(3):303-310. PubMed ID: 30907196 [No Abstract] [Full Text] [Related]
12. An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme. Kelley L; Swan N; Hughes DJ Colorectal Dis; 2013 Sep; 15(9):e512-21. PubMed ID: 23746062 [TBL] [Abstract][Full Text] [Related]
13. Association Between Concentrations of Hemoglobin Determined by Fecal Immunochemical Tests and Long-term Development of Advanced Colorectal Neoplasia. Grobbee EJ; Schreuders EH; Hansen BE; Bruno MJ; Lansdorp-Vogelaar I; Spaander MCW; Kuipers EJ Gastroenterology; 2017 Nov; 153(5):1251-1259.e2. PubMed ID: 28760383 [TBL] [Abstract][Full Text] [Related]
14. Long-term performance of colorectal cancerscreening programmes based on the faecal immunochemical test. Zorzi M; Hassan C; Capodaglio G; Fedato C; Montaguti A; Turrin A; Rosano A; Monetti D; Stocco C; Baracco S; Russo F; Repici A; Rugge M Gut; 2018 Dec; 67(12):2124-2130. PubMed ID: 29101260 [TBL] [Abstract][Full Text] [Related]
15. The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut-off level on yield of screening. Kooyker AI; Toes-Zoutendijk E; Opstal-van Winden AWJ; Spaander MCW; Buskermolen M; van Vuuren HJ; Kuipers EJ; van Kemenade FJ; Ramakers C; Thomeer MGJ; Dekker E; Nagtegaal ID; de Koning HJ; van Leerdam ME; Lansdorp-Vogelaar I Int J Cancer; 2020 Aug; 147(4):1098-1106. PubMed ID: 31853977 [TBL] [Abstract][Full Text] [Related]
16. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening. Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679 [TBL] [Abstract][Full Text] [Related]
17. Does Low Threshold Value Use Improve Proximal Neoplasia Detection by Fecal Immunochemical Test? Kim NH; Yang HJ; Park SK; Park JH; Park DI; Sohn CI; Choi K; Jung YS Dig Dis Sci; 2016 Sep; 61(9):2685-93. PubMed ID: 27107865 [TBL] [Abstract][Full Text] [Related]
18. Factors associated with interval colorectal cancer after negative FIT: Results of two screening rounds in the Dutch FIT-based CRC screening program. Breekveldt ECH; Toes-Zoutendijk E; van de Schootbrugge-Vandermeer HJ; de Jonge L; Kooyker AI; Spaander MCW; van Vuuren AJ; van Kemenade FJ; Ramakers C; Dekker E; Nagtegaal ID; van Leerdam ME; Lansdorp-Vogelaar I Int J Cancer; 2023 Apr; 152(8):1536-1546. PubMed ID: 36444504 [TBL] [Abstract][Full Text] [Related]
19. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer. Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194 [TBL] [Abstract][Full Text] [Related]
20. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing. van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]